Loading...
VentriPoint Diagnostics Ltd.
VPTDF•PNK
Healthcare
Medical - Devices
$0.11
$0.00(0.00%)
VentriPoint Diagnostics Ltd. (VPTDF) Financial Performance & Income Statement Overview
Review VentriPoint Diagnostics Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
93.51%
↑ 93.51%
Operating Income Growth
2.61%
↑ 2.61%
Net Income Growth
-0.98%
↓ 0.98%
Operating Cash Flow Growth
10.98%
↑ 10.98%
Operating Margin
-2687.75%
↓ 2687.75%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-2816.90%
↓ 2816.90%
ROE
170.09%
↑ 170.09%
ROIC
133.79%
↑ 133.79%
VentriPoint Diagnostics Ltd. (VPTDF) Income Statement & Financial Overview
Review VentriPoint Diagnostics Ltd.'s (VPTDF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $64507.00 | $30665.00 | $0.00 |
| Cost of Revenue | $0.00 | $15514.00 | $0.00 | $16177.00 |
| Gross Profit | $0.00 | $48993.00 | $30665.00 | -$16177.00 |
| Gross Profit Ratio | $0.00 | $0.76 | $1.00 | |
| R&D Expenses | $191819.00 | $270516.00 | $299258.00 | $207650.00 |
| SG&A Expenses | $859645.00 | $972487.00 | $1.11M | $949652.00 |
| Operating Expenses | $1.05M | $1.24M | $1.41M | $1.16M |
| Total Costs & Expenses | $1.05M | $1.26M | $1.41M | $1.17M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $64409.00 | $32270.00 | $7249.00 |
| Depreciation & Amortization | $15437.00 | $15514.00 | $15743.00 | $16177.00 |
| EBITDA | -$1.06M | -$1.18M | -$1.37M | -$1.17M |
| EBITDA Ratio | -$18.27 | -$44.72 | ||
| Operating Income | -$1.05M | -$1.19M | -$1.38M | -$1.17M |
| Operating Income Ratio | -$18.51 | -$45.10 | ||
| Other Income/Expenses (Net) | -$91626.00 | -$57069.00 | -$36575.00 | -$15962.00 |
| Income Before Tax | -$1.14M | -$1.25M | -$1.42M | -$1.19M |
| Income Before Tax Ratio | -$19.39 | -$46.29 | ||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $3.00 |
| Net Income | -$1.06M | -$1.25M | -$1.42M | -$1.19M |
| Net Income Ratio | -$19.39 | -$46.29 | ||
| EPS | -$0.007 | -$0.008 | -$0.009 | -$0.008 |
| Diluted EPS | -$0.007 | -$0.008 | -$0.009 | -$0.008 |
| Weighted Avg Shares Outstanding | $158.28M | $157.48M | $157.18M | $157.14M |
| Weighted Avg Shares Outstanding (Diluted) | $158.28M | $157.48M | $157.18M | $157.14M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan